antiviral treatment

April 30, 2015April 30, 2015

Study Reveals Hepatitis E Vaccine Can Protect Up to 4.5 Years

Hepatitis E, News

A new study conducted by a research group in China assessed a vaccine for Hepatitis E. The vaccine caused the production of antibodies and protected vaccine recipients from hepatitis E for up to ... Read more

April 22, 2015April 22, 2015

Cancer Drugs Being Tested To Combat Chronic Hepatitis B

Hepatitis B

Australia is on the verge of becoming a pioneer in formulating a possible cure for chronic Hepatitis B infections and related complications, like cirrhosis and liver cancer. According to a recent press ... Read more

March 31, 2015March 31, 2015

Over-accumulation of Iron Associated in Hepatitis C Implicated in Liver Damage

Hepatitis C, News

Findings from the study titled “Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver,” published in the World Journal of Gastroenterology indicate that an over-accumulation ... Read more

March 2, 2015March 2, 2015

Ciclofilin Pharmaceuticals to Present Abstract on Hepatitis Antiviral at EASL 2015

News

Ciclofilin Pharmaceuticals, Inc., a biotechnology company based in San Diego, California committed to developing broad spectrum, antivirals has recently announced that Philippe Gallay of the Scripps Research Institute will be presenting a co-authored abstract ... Read more

February 17, 2015February 17, 2015

Study Reveals That Chemotherapy or Immunosuppressive Treatment May Reactivate HBV

Hepatitis B, News

A new review on the effect of Chemotherapy or immunosuppressive therapy in reactivation of Hepatitis B virus infection entitled “Recent US Food and Drug Administration warnings on hepatitis B reactivation ... Read more